Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
about
Osteoclasts are active in bone forming metastases of prostate cancer patientsA novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionRole of osteocytes in multiple myeloma bone diseaseDiagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvementMechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone RemodelingGlucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetesNeovascular niche for human myeloma cells in immunodeficient mouse boneMyeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.Osteoblastogenesis and tumor growth in myeloma.Advances in the understanding of myeloma bone disease and tumour growth.Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysisThe effects of proteasome inhibitors on bone remodeling in multiple myeloma.Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeuticsBone disease in multiple myeloma: pathophysiology and management.First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.Hematopoietic cell regulation of osteoblast proliferation and differentiation.Layer-by-layer paper-stacking nanofibrous membranes to deliver adipose-derived stem cells for bone regenerationDkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblastsNOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in boneBone anabolic agents for the treatment of multiple myeloma.Targeting bone as a therapy for myeloma.Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche.Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoB cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivoThe KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone DiseaseMyeloma as a model for the process of metastasis: implications for therapyTherapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthTug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?Effects of growth factors and cytokines on osteoblast differentiation.Role of the microenvironment in multiple myeloma bone disease.Stem-cell ecology and stem cells in motionBidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple MyelomaThe effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.Treatment strategies for bone disease.Cellular mechanisms of multiple myeloma bone diseaseMyeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma.
P2860
Q21090081-336F416C-6DBA-4241-AEC7-68DCB666A19AQ24297354-37A660FB-92C4-44B8-AFB4-F81BDD03B05AQ26992195-D4E35E40-98D2-4EFF-BC46-42D75764B7DCQ27011865-443F07C8-56C6-44A0-A905-D34D594C8E56Q28082335-1AFB6614-B591-4AE9-9AF5-829580AB01FDQ28546539-D8F9D9FF-F916-4ED8-889D-2ACC6718104FQ28732210-5B35FDB8-B8DD-4D5D-8AC1-9E8A96168AE9Q33558170-1CFAC048-EE2B-41A8-A826-45E619F23C39Q33564854-646E519C-8302-4F6D-BB81-1D57959D520EQ33695185-100784B6-5C74-4451-A9B4-07684999FD6CQ33768466-F15B9734-53AC-4C2E-AC22-CEB2F338855AQ33829022-0A263297-93E8-4423-A6BF-0B0BAEDC0456Q33854017-2729EC3E-C51A-4777-A3D2-F44CE119B16CQ33918020-A5FCA367-D048-475B-B014-E9E4D893BF1AQ34038854-9E445BE2-8525-4365-82FF-6AB65508C21CQ34045789-3DE06CF2-342E-4C72-B7A0-3756A799DFC5Q34269238-6D7C310E-D9C8-4CC3-A911-F6F5143EA5DCQ34973819-2B8D12DF-1F50-4633-9B49-B14929A56CD2Q35101019-9825FE5A-B353-43E7-B97E-9987524F044CQ35144762-F1D922ED-4042-4465-BEC0-4AC7A71DA266Q35175289-6EC3B520-5C24-47BF-A0A7-7FECE2D445D3Q35219019-9464FB93-0F7D-4BE1-A719-BA3FD2D5074FQ35603116-456EBFEC-0B14-4BC1-B630-96D9EEF73845Q35603128-82BFE695-132B-4BA7-A96B-EDEF240AD8E4Q35631319-8F0425E7-ABFF-40B1-8D77-6A1074013695Q35631433-6DD065C4-F254-4926-BA11-88927C0E7BFEQ35642745-72B565E3-56DB-47DD-9214-C4E093681DEEQ35804512-1E85909A-91A2-4F21-BA60-25140EE9BE6AQ36011988-9510B917-3E6A-4426-8DB0-46AB2C0E36F4Q36079800-702ABFD6-2132-4F14-8DCA-7463CB909443Q36092153-58B83C4A-F672-4563-BB3F-DA32ECB59464Q36289608-E195C260-8BB9-4286-9BB8-576C58683CADQ36474269-E16B372A-94D5-4E8D-81FE-49F5294EC4B5Q36512521-5384EBBD-729B-4164-9744-61D8379E3D5FQ36528727-9EA1F28D-AD02-4AC9-A8F9-5AC59D5BE705Q36642956-36F3E9A4-B355-46FA-8CDC-2BE16E4C500FQ36870585-CE339623-CE77-4508-AEDE-659341D10C1FQ36902828-B73A0F79-833A-49F1-8A02-DB628204986CQ36925346-2A540057-27C3-4A05-A451-B745D2076075Q37027406-06CB26D9-7C0C-493F-BA2A-6A589B406F73
P2860
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Myeloma cells block RUNX2/CBFA ...... formation and differentiation.
@en
type
label
Myeloma cells block RUNX2/CBFA ...... formation and differentiation.
@en
prefLabel
Myeloma cells block RUNX2/CBFA ...... formation and differentiation.
@en
P2093
P50
P1433
P1476
Myeloma cells block RUNX2/CBFA ...... formation and differentiation.
@en
P2093
Francesca Morandi
Mirca Lazzaretti
Mirija Svaldi
Sabrina Bonomini
Vittorio Rizzoli
P304
P356
10.1182/BLOOD-2004-12-4986
P407
P577
2005-06-02T00:00:00Z